Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial. Fearon WF, Terada K, Takahashi K, Skoda A, et al. Circulation 2026;153:7-17.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fearon WF, Terada K, Takahashi K, Skoda A, et al. Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial. Circulation 2026;153:7-17.
PMID: 41212178